tirzepatide side effects heart Bridging the gap between GLP1-receptor agonists and cardiovascular outcomes: evidence for the role of | Cardiovascular Diabetology Comparative safety and side effects

Insomnia is an inability to fall asleep or stay asleep long enough to feel well-rested and refreshed in the morning.

24

The evidence base in support of the use of medicines based on glucagon-like peptide 1 beyond glucose control and weight loss was substantially bolstered in 2024, as clinical trial data report benefits of these medicines in people with a range of disorders.

Glucagon-like peptide-1 receptor agonists show promise for reducing apnea-hypopnea index and body weight in patients with obstructive sleep apnea, offering new treatment options beyond PAP therapy.

Learn common causes of dizziness with GLP-1 therapy and ways to support hydration, nutrition, and recovery.